Skip to main content
Log in

Antiemetic treatment for cancer chemotherapy: problems and progress

  • Editorial
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Aapro MS (1994) Costs and benefits of antiemetic therapy. Support Care Cancer 2: 304–306

    Google Scholar 

  2. Billett AL, Sallan SE (1994) Antiemetics in children receiving cancer chemotherapy. Support Care Cancer 2: 279–285

    Google Scholar 

  3. Grunberg SM (1994) Future of the management of emesis. Support Care Cancer 2:301–303

    Google Scholar 

  4. Hesketh PJ (1994) Treatment of chemotherapy-induced emesis in the 1990s: impact of the 5-HT3 receptor antagonists. Support Care Cancer 2:286–292

    Google Scholar 

  5. Kris MG, Pisters KMW, Hinkley L (1994) Delayed emesis following anti-cancer chemotherapy. Support Care Cancer 2:297–300

    Google Scholar 

  6. Rubenstein EB (1994) Costs and benefits of outpatient therapy. Support Care Cancer 2:307–311

    Google Scholar 

  7. Tonato M, Roila F, Del Favero A (1994) Are there differences among the serotonin antagonists? Support Care Cancer 2:293–296

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gralla, R.J. Antiemetic treatment for cancer chemotherapy: problems and progress. Support Care Cancer 2, 275–276 (1994). https://doi.org/10.1007/BF00365576

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00365576

Navigation